- Lobbying
- Lobbying by Sema4 (formerly known as Mount Sinai Genomics, Inc. (d/b/a Sema4))
Lobbying Relationship
Bills mentioned
S.4348: FDASLA Act of 2022
Sponsor: Patty Murray (D-Wash.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jennifer Leib | Fellow, Senate Committee on Health, Education, Labor, and Pensions Fellow, Senate Committee on Health, Education, Labor and Pensions Legislative Fellow, Senate Committee on Health, Education, Labor, and Pensions Fellow, Senate Health, Education, Labor and Pensions Committee |
Megan Anderson Brooks | n/a |
Megan Anderson Brooks | n/a |
Jay Qiu | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare reimbursement for comprehensive genomic profiling.
Q3 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Q1 Report
Q4 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate